AMGEN INC AMGN

Latest FY: 2025 Healthcare Drug Manufacturers - General
Market Price $415.16
Market Cap $225.51B
P/E Ratio 29.17
Quick Peer Compare (Healthcare):
Revenue (FY 2025) ↑10.0% YoY
$36.75B
3-Yr CAGR: 11.8%
Net Income ↑88.5% YoY
$7.71B
Net Margin: 21.0%
Free Cash Flow ↓-22.1% YoY
$8.10B
FCF Yield: 3.59%
EPS (Diluted) ↑88.2% YoY
$14.23
Basic: $14.33
Return on Equity Efficiency
89.1%
ROA: 8.5%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (AMGN)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $22,991.0M $18,829.0M $7,722.0M $10.24 $10,354.0M $9,616.0M
FY 2017 $22,849.0M -0.6% $18,780.0M $1,979.0M -74.4% $2.69 -73.7% $11,177.0M $10,513.0M +9.3%
FY 2018 $23,747.0M +3.9% $19,646.0M $8,394.0M +324.2% $12.62 +369.1% $11,296.0M $10,558.0M +0.4%
FY 2019 $23,362.0M -1.6% $19,006.0M $7,842.0M -6.6% $12.88 +2.1% $9,150.0M $8,532.0M -19.2%
FY 2020 $25,424.0M +8.8% $19,265.0M $7,264.0M -7.4% $12.31 -4.4% $10,497.0M $9,889.0M +15.9%
FY 2021 $25,979.0M +2.2% $19,525.0M $5,893.0M -18.9% $10.28 -16.5% $9,261.0M $8,381.0M -15.2%
FY 2022 $26,323.0M +1.3% $19,917.0M $6,552.0M +11.2% $12.11 +17.8% $9,721.0M $8,785.0M +4.8%
FY 2023 $28,190.0M +7.1% $19,739.0M $6,717.0M +2.5% $12.49 +3.1% $8,471.0M $7,359.0M -16.2%
FY 2024 $33,424.0M +18.6% $20,566.0M $4,090.0M -39.1% $7.56 -39.5% $11,490.0M $10,394.0M +41.2%
FY 2025 $36,751.0M +10.0% $24,714.0M $7,711.0M +88.5% $14.23 +88.2% $9,958.0M $8,100.0M -22.1%
$

Valuation

Market Price $415.16
Market Cap $225.51B
Enterprise Value $270.99B
P/E Ratio 29.17
P/B Ratio 25.88
FCF Yield 3.59%
Dividend Yield 2.33%
Shares Outstanding 539,708,300
%

Profitability & Margins

Gross Margin 67.25%
Operating Margin 24.71%
Net Margin 20.98%
Return on Equity (ROE) 89.06%
Return on Assets (ROA) 8.51%
Asset Turnover 0.41x
Revenue 3-Yr CAGR 11.77%
🛡️

Financial Health & Liquidity

Current Ratio 1.57
Cash Ratio 0.49
Debt / Equity 6.307
Debt / Assets 0.603
Cash & Equivalents $9.13B
Total Debt $54.60B
Book Value / Share $16.04
💧

Cash Flow Efficiency

Operating Cash Flow $9.96B
Capital Expenditures (CapEx) $1.86B
Free Cash Flow $8.10B
OCF / Revenue 27.10%
FCF / Revenue 22.04%
FCF 3-Yr CAGR -2.67%
🏷️

Per Share Metrics

EPS (Diluted) $14.23
EPS (Basic) $14.33
Dividends / Share $9.66
Book Value / Share $16.04
EPS YoY Growth 88.23%
🏛️

Balance Sheet (FY 2025)

Total Assets $90.59B
Total Liabilities $90.59B
Stockholders' Equity $8.66B
Current Assets $29.06B
Current Liabilities $18.52B